ICDcodes.org
FY2027

T45.625SAdverse effect of hemostatic drug, sequela

Billable

Is T45.625S billable?

Yes — T45.625S is billable for FY2027. T45.625S is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. T45.625S may be submitted for encounters from October 1, 2026 through September 30, 2027.

T45.625S at a glance

CodeT45.625S
DescriptionAdverse effect of hemostatic drug, sequela
BillableYes
Code setICD-10-CM FY2027
Valid for encountersOctober 1, 2026 – September 30, 2027
7th character "S"sequela

What does the 7th character "S" mean in T45.625S?

In T45.625S, the 7th character S means sequela. The 7th character is required for T45.625S to be a valid, complete code.

Same condition, different episode of care — switch the 7th character:

What Medicare edits apply to T45.625S?

The Medicare Code Editor screens inpatient claims before they are grouped. These edits name T45.625S directly.

Cannot be a principal diagnosis — MCE edit 9

CMS will reject this code as the principal diagnosis on an inpatient claim. It describes something other than the condition chiefly responsible for the admission.

Which MS-DRGs does T45.625S group to?

T45.625S sits in MDC 21 and helps define the logic of 2 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.

  • 922Other Injury, Poisoning and Toxic Effect Diagnoses with MCCmedical
  • 923Other Injury, Poisoning and Toxic Effect Diagnoses without MCCmedical

Excludes1 — never code together — inherited from T36-T50

The conditions below can never be reported together with T45.625S on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • toxic reaction to local anesthesia in pregnancy (O29.3-)

Code first — inherited from T36-T50

The underlying condition below must be sequenced before T45.625S. T45.625S describes a manifestation and cannot be the principal or first-listed diagnosis.

  • , for adverse effects, the nature of the adverse effect, such as:
  • adverse effect NOS (T88.7)
  • aspirin gastritis (K29.-)
  • blood disorders (D56-D76)
  • contact dermatitis (L23-L25)
  • dermatitis due to substances taken internally (L27.-)
  • nephropathy (N14.0-N14.2)

Use additional code — inherited from Chapter 19

Report an additional code alongside T45.625S to fully describe the condition. T45.625S is sequenced first.

  • code to identify any retained foreign body, if applicable (Z18.-)

Use additional code — inherited from T36-T50

Report an additional code alongside T45.625S to fully describe the condition. T45.625S is sequenced first.

  • code(s) to specify:
  • manifestations of poisoning
  • underdosing or failure in dosage during medical and surgical care (Y63.6, Y63.8-Y63.9)
  • underdosing of medication regimen (Z91.12-, Z91.13-)

Excludes2 — not included here — inherited from Chapter 19

The conditions below are not part of T45.625S, but a patient may have both at the same time. When documentation supports it, T45.625S and the excluded code may both be reported.

  • birth trauma (P10-P15)
  • obstetric trauma (O70-O71)

Excludes2 — not included here — inherited from T36-T50

The conditions below are not part of T45.625S, but a patient may have both at the same time. When documentation supports it, T45.625S and the excluded code may both be reported.

  • abuse and dependence of psychoactive substances (F10-F19)
  • abuse of non-dependence-producing substances (F55.-)
  • immunodeficiency due to drugs (D84.821)
  • drug reaction and poisoning affecting newborn (P00-P96)
  • pathological drug intoxication (inebriation) (F10-F19)

How long has T45.625S existed?

T45.625S has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.

Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.